KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 0.45.

  • Abbott Laboratories' FCF Payout Ratio rose 73.93% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58, marking a year-over-year increase of 69.08%. This contributed to the annual value of 0.6 for FY2024, which is 1407.11% down from last year.
  • Latest data reveals that Abbott Laboratories reported FCF Payout Ratio of 0.45 as of Q3 2025, which was up 73.93% from 0.67 recorded in Q2 2025.
  • Abbott Laboratories' 5-year FCF Payout Ratio high stood at 1.53 for Q1 2024, and its period low was 0.33 during Q4 2021.
  • In the last 5 years, Abbott Laboratories' FCF Payout Ratio had a median value of 0.47 in 2021 and averaged 0.63.
  • As far as peak fluctuations go, Abbott Laboratories' FCF Payout Ratio crashed by 8012.76% in 2021, and later skyrocketed by 21366.09% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' FCF Payout Ratio stood at 0.33 in 2021, then skyrocketed by 47.43% to 0.48 in 2022, then fell by 18.9% to 0.39 in 2023, then grew by 14.66% to 0.45 in 2024, then rose by 0.9% to 0.45 in 2025.
  • Its FCF Payout Ratio was 0.45 in Q3 2025, compared to 0.67 in Q2 2025 and 1.1 in Q1 2025.